HRMY Q1 2024 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$155M+29.8% YoY

Gross Profit

$127M82.2% margin

Operating Income

$52M33.7% margin

Net Income

$38M24.8% margin

EPS (Diluted)

$0.67

QoQ Revenue Growth

-8.2%

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$31M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$847M

Total Liabilities

$332M

Stockholders' Equity

$515M

Cash & Equivalents

$333M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$155M	$119M	+29.8%
Gross Profit	$127M	$98M	+29.3%
Operating Income	$52M	$40M	+28.7%
Net Income	$38M	$29M	+30.0%